Frequency of novel N-glycosylation sites in disease cohorts compared to normal memory B cells and plasma cells
| Cohort . | Homology to GL (%) . | No. patients analyzed . | No. patients with new sites (%) . | Statistical significance* . | |
|---|---|---|---|---|---|
| Median . | Range . | ||||
| FL | 88 | 76-96 | 70 | 55 (79) | P < .001 |
| DLCL | 88 | 78-99 | 32 | 13 (41) | P = .014 |
| Mutated CLL | 92 | 86-94 | 40 | 5 (13) | NS |
| MM | 92 | 84-97 | 64 | 5 (8) | NS |
| Normal | 91 | 83-95 | 75 | 7 (9) | — |
| Cohort . | Homology to GL (%) . | No. patients analyzed . | No. patients with new sites (%) . | Statistical significance* . | |
|---|---|---|---|---|---|
| Median . | Range . | ||||
| FL | 88 | 76-96 | 70 | 55 (79) | P < .001 |
| DLCL | 88 | 78-99 | 32 | 13 (41) | P = .014 |
| Mutated CLL | 92 | 86-94 | 40 | 5 (13) | NS |
| MM | 92 | 84-97 | 64 | 5 (8) | NS |
| Normal | 91 | 83-95 | 75 | 7 (9) | — |
Compared to normal cell cohort (χ2test).
NS indicates not significant.